Targeting cancer cell sialylation with monosaccharide analogues modulates EGFR in colorectal cancer cells
{{output}}
Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide, mainly due to resistance to targeted therapies such as Cetuximab, a chimeric monoclonal antibody targeting epidermal growth factor receptor (EGFR) used in RAS wild-type tum... ...
